Raloxifene - PDFSEARCH.IO - Document Search Engine

Raloxifene
Results: 94

#	Item
41	Embargoed for Release: 7:30 a.m. CT, Dec. 12, 2013 To interview Jack Cuzick, contact Charli Scouller at [removed] or +[removed]or the Cancer Research U.K. press office at +[removed]For a photo o Add to Reading List Source URL: www.sabcs.org Language: English - Date: 2013-12-06 15:23:00 Aromatase inhibitors Selective estrogen receptor modulators AstraZeneca Ribbon symbolism Endocrinology Breast cancer Tamoxifen Raloxifene Anastrozole Medicine Chemistry Endocrine system
42	Microsoft Word - Bone Resorption Suppression and Related Agents Jan 2010.doc Add to Reading List Source URL: www.oregon.gov Language: English - Date: 2014-07-15 14:00:37 Anatomy Osteoporosis Alendronic acid Teriparatide Osteonecrosis of the jaw Hypercalcaemia Etidronic acid Raloxifene Risedronic acid Bisphosphonates Medicine Chemistry
43	Microsoft Word - last final benigh breast disease release.doc Add to Reading List Source URL: www.nsabp.pitt.edu Language: English - Date: 2001-12-10 12:04:40 Selective estrogen receptor modulators Organic chemistry Study of Tamoxifen and Raloxifene clinical research Breast cancer Tamoxifen Raloxifene Fibrocystic breast changes Cancer Medicine Breast diseases Chemistry
44	CancerNet Logo No Tag White S Add to Reading List Source URL: www.cancer.net Language: English - Date: 2013-07-08 15:58:55 Ribbon symbolism Aromatase inhibitors Eli Lilly and Company Raloxifene Tamoxifen Menopause Exemestane Cancer Estrogen Medicine Selective estrogen receptor modulators Breast cancer
45	Patient Information Resources from ASCO What to Know ASCO’s Guideline on Drugs to Lower Breast Cancer Risk JULY 2013 Add to Reading List Source URL: www.cancer.net Language: English - Date: 2013-07-08 16:04:16 Aromatase inhibitors Ribbon symbolism Breast cancer Alkenes Tamoxifen Raloxifene Menopause Exemestane Hot flash Medicine Chemistry Selective estrogen receptor modulators
46	EMBARGOED FOR RELEASE 4 p.m. EDT Monday, September 14, 1998 NCI Press Office[removed] Add to Reading List Source URL: www.nsabp.pitt.edu Language: English - Date: 2001-03-13 11:30:24 Ribbon symbolism Eli Lilly and Company Phenols Alkenes Tamoxifen Study of Tamoxifen and Raloxifene Raloxifene Breast cancer Cancer Medicine Chemistry Selective estrogen receptor modulators
47	EMBARGOED FOR RELEASE 4 p.m., EDT Monday, September 14, 1998 NCI Press Office[removed] Add to Reading List Source URL: www.nsabp.pitt.edu Language: English - Date: 2001-03-13 11:30:24 Clinical trials Menopause Alkenes AstraZeneca Tamoxifen Study of Tamoxifen and Raloxifene Raloxifene Aromatase inhibitor Breast cancer Medicine Chemistry Selective estrogen receptor modulators
48	Cooperative Extension Bone Builders The University of Arizona April, May, June 2005 Add to Reading List Source URL: cals.arizona.edu Language: English - Date: 2006-02-12 22:51:36 Aging-associated diseases Selective estrogen receptor modulators Osteopathies Geriatrics Osteoporosis Raloxifene Bone density Bisphosphonate Bone Medicine Health Anatomy
49	Ackrnowledgement and Consent for Disclosure of Potential Con.flict(s) of Interest and a Waiver under 21 U.S.C. $355 (n)(4) Maha Hussain, M.D. Committee: Add to Reading List Source URL: www.fda.gov Language: English - Date: 2007-07-09 08:23:20 Selective estrogen receptor modulators Phenols Piperidines Eli Lilly and Company Raloxifene Endocrinology Osteoporosis Menopause Breast cancer Chemistry Organic chemistry Medicine
50	Prior Authorization Request Form for Forteo (teriparatide) Add to Reading List Source URL: mainecarepdl.org Language: English - Date: 2012-04-02 14:06:01 Anatomy Drugs Osteopathies Osteoporosis Teriparatide Raloxifene Bisphosphonate Bone density Bone Eli Lilly and Company Medicine Chemistry